Publications by authors named "Anne-Sophie Baumann"
Introduction: This document is a summary of the French Intergroup guidelines regarding the management of hepatocellular carcinoma (HCC) published in March 2019.
Method: It is a collaborative work under the auspices of most of the French medical societies involved in the management of HCC. It is based on the previous guidelines published in 2017.
Purpose: Liver transplantation is the standard definitive treatment for nonmetastatic hepatocellular carcinoma (HCC). However, less than 5% of patients are ultimately candidates as a result of frequent comorbidities and graft shortage. The aim of this study was to evaluate stereotactic body radiation therapy (SBRT) as an ablative treatment for inoperable HCC.
View Article and Find Full Text PDFIntroduction: This document is a summary of the French Intergroup guidelines regarding the management of gastric cancer published in October 2016, available on the website of the French Society of Gastroenterology (SNFGE) (www.tncd.org), updated in October 2017.
View Article and Find Full Text PDFArticle Synopsis
- This study investigates late rectal and urinary toxicities in prostate cancer patients who underwent intensity-modulated radiotherapy (IMRT) at different radiation doses (70Gy, 74Gy, and 80Gy) and aims to find predictors of radiation toxicity and biochemical progression-free survival (bPFS).
- The results show that after a median follow-up of 77 months, the cumulative rate of late grade ≥2 rectal and urinary toxicities was 6.3% and 25.3%, respectively, with only dose and baseline symptom scores influencing the likelihood of these toxicities.
- Biochemical relapse-free survival rates after five years were substantial, varying by risk group (97.5% for low, 84
Purpose: To describe efficacy and safety of stereotactic body radiation therapy (SBRT) for the treatment of inoperable hepatocellular carcinoma.
Methods: The records of 77 consecutive patients treated with SBRT for 97 liver-confined HCC were reviewed. A total dose of 45Gy in 3 fractions was prescribed to the 80% isodose line.